Literature DB >> 2556881

Induction of glutathione S-transferase, placental type in T9 glioma cells by dibutyryladenosine 3',5'-cyclic monophosphate and modification of its expression by naturally occurring isothiocyanates.

A Hara1, N Sakai, H Yamada, T Tanaka, K Kato, H Mori, K Sato.   

Abstract

The effect of dibutyryladenosine 3',5'-cyclic monophosphate (dibutyryl cAMP) on the expression of glutathione S-transferase placental type (GST-P) was examined in rat glioma cell line using an immunohistochemical technique. Cultured T9 glioma cells were negative for GST-P activity under normal conditions. However, treatment with 1 mM dibutyryl cAMP produced GST-P expression in about 50% of the cells, as well as some morphological changes. The expression of GST-P was increased with addition of dibutyryl cAMP together with 1 microgram/ml allyl isothiocyanate (AITC) or 0.1 microgram/ml benzyl isothiocyanate (BITC). With these combinated treatments, almost all cultured cells showed a strong positive reaction for GST-P, although AITC or BITC alone elicited GST-P in only 5% of the cultured cells. The results of the present study indicate that dibutyryl cAMP causes functional as well as morphological differentiation of T9 glioma cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556881     DOI: 10.1007/BF00294371

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  28 in total

1.  Induction of some features of glial differentiation in primary cultures of human gliomas by treatment with dibutyrl cyclic AMP.

Authors:  L W Haynes; R O Weller
Journal:  Br J Exp Pathol       Date:  1978-06

2.  Isolation and spectral studies on the calcium binding properties of bovine brain S-100a protein.

Authors:  R S Mani; C M Kay
Journal:  Biochemistry       Date:  1983-08-02       Impact factor: 3.162

3.  Carcinogenesis bioassay of allyl isothiocyanate.

Authors:  J K Dunnick; J D Prejean; J Haseman; R B Thompson; H D Giles; E E McConnell
Journal:  Fundam Appl Toxicol       Date:  1982 May-Jun

4.  Ca2+, K+-regulated intramolecular crosslinking of S-100 protein via disulfide bond formation.

Authors:  P Calissano; D Mercanti; A Levi
Journal:  Eur J Biochem       Date:  1976-12

5.  [Cyclic AMP and malignant glioma. 1. Effects of dibutyryl adenosine cyclic 3',5'-monophosphate on malignant glioma cells].

Authors:  T Kanno; T Nakazawa; Y Kato
Journal:  Rinsho Shinkeigaku       Date:  1972-11

6.  Inhibitory effects of benzyl isothiocyanate administered shortly before diethylnitrosamine or benzo[a]pyrene on pulmonary and forestomach neoplasia in A/J mice.

Authors:  L W Wattenberg
Journal:  Carcinogenesis       Date:  1987-12       Impact factor: 4.944

7.  Effects of disulfiram, diethyldithiocarbamate, bisethylxanthogen, and benzyl isothiocyanate on glutathione transferase activities in mouse organs.

Authors:  A M Benson; P B Barretto
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

8.  Tumor-specific transplantation immunity to intracerebral challenge with cells from a methylnitrosourea- induced brain tumor.

Authors:  R H Denlinger; D A Axler; A Koestner; L Liss
Journal:  J Med       Date:  1975

9.  Evaluation of the drug-induced morphological differentiation of rat glioma cells (C-6) from the aspects of S-100 protein level and con A binding pattern.

Authors:  K Tabuchi; T Furuta; H Norikane; M Tsuboi; Y Moriya; A Nishimoto
Journal:  J Neurol Sci       Date:  1981-07       Impact factor: 3.181

10.  The responses in culture of human tumour astrocytes and neuroblasts to N 6 , O 2' -dibutyryl adenosine 3',5'-monophosphoric acid.

Authors:  E H Macintyre; C J Wintersgill; J P Perkins; A E Vatter
Journal:  J Cell Sci       Date:  1972-11       Impact factor: 5.285

View more
  6 in total

Review 1.  Phenethyl isothiocyanate: a comprehensive review of anti-cancer mechanisms.

Authors:  Parul Gupta; Stephen E Wright; Sung-Hoon Kim; Sanjay K Srivastava
Journal:  Biochim Biophys Acta       Date:  2014-08-23

2.  Correlation between nucleolar organizer region score and bromodeoxyuridine labeling index in C6 glioma cell line.

Authors:  A Hara; S Niikawa; H Hirayama; N Sakai; H Yamada; T Ohno; T Tanaka; H Mori
Journal:  J Neurooncol       Date:  1991-10       Impact factor: 4.130

3.  Preliminary individual adjuvant therapy for gliomas based on the results of molecular biological analyses for drug-resistance genes.

Authors:  S Tanaka; H Kamitani; M R Amin; T Watanabe; H Oka; K Fujii; T Nagashima; T Hori
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

4.  Identification of placental form of glutathione S-transferase in ACNU-resistant murine glioma cell lines.

Authors:  A Hara; S Niikawa; W Zhang; N Sakai; H Yamada; N Yoshimi; H Mori
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

5.  Expression of the placental form of glutathione S-transferase in pediatric gliomas.

Authors:  A Hara; N Sakai; H Yamada; S Niikawa; N Yoshimi; H Mori; K Shimokawa
Journal:  Childs Nerv Syst       Date:  1993-06       Impact factor: 1.475

6.  Immunoblot analysis of the placental form of glutathione S-transferase in protein extracted from paraffin-embedded human glioma tissue.

Authors:  A Hara; N Sakai; H Yamada; N Yoshimi; T Tanaka; H Mori
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.